InMed Pharmaceuticals Inc.
Ticker: 1728328
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY2026 | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.82-26.8% | 1.12-11.1% | 1.26+13.5% | 1.11-11.9% | 1.26+7.7% | 1.17-5.6% | 1.24+37.8% | 0.90 |
| Total Income | 0.82-26.8% | 1.12-11.1% | 1.26+13.5% | 1.11-11.9% | 1.26+7.7% | 1.17-5.6% | 1.24+37.8% | 0.90 |
| EXPENSES | ||||||||
| Expenditure | 2.85+0.0% | 2.85-15.7% | 3.38-8.4% | 3.69+25.5% | 2.94+1.4% | 2.90+6.6% | 2.72-20.9% | 3.44 |
| PROFIT | ||||||||
| PBT | -2.03-17.3% | -1.73+18.4% | -2.12+17.8% | -2.58-53.6% | -1.68+2.3% | -1.72-16.2% | -1.48+41.7% | -2.54 |
| Net Profit | -2.03-17.3% | -1.73+18.4% | -2.12+17.8% | -2.58-53.6% | -1.68+2.3% | -1.72-16.2% | -1.48+41.7% | -2.54 |
| KEY METRICS | ||||||||
| OPM % | — | — | — | — | — | — | — | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.51-15.9% | -0.44+77.3% | -1.94+46.7% | -3.64-34.3% | -2.71-1405.6% | -0.18+5.3% | -0.19+75.0% | -0.76 |
Corporate Events
Board MeetingINM
202619May
Board Meeting
Merger Agreement between InMed Pharmaceuticals Inc. and Ment…
SEC Filing ↗